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Abstract
Background: There is limited research defining the true prevalence of anal incontinence (AI) in women of
childbearing age. Understanding the limitations of the current assessment tools in the identification of AI is
paramount for identifying the prevalence of AI and improving the care and management for women of
childbearing age. The aim of this research was to explore and develop an understanding of women’s experiences
in disclosing AI when completing a new bowel-screening questionnaire when compared to two established AI
tools.
Methods: A phenomenological qualitative research study was undertaken in a maternity setting in a large tertiary
hospital. Parous women in the first trimester of a subsequent pregnancy were recruited to complete a specifically
designed screening tool (BSQ), St Marks Faecal incontinence score (Vaizey) and Cleveland (Wexner) score. Qualitative
semi-structured interviews were utilised to identify experiences in disclosing AI.
Results: Women (n = 16, 22–42 years) with a history of anal incontinence either following the first birth (n = 12) or the
second (n = 4) provided differing responses between the three assessment tools. All women answered the BSQ while
the Vaizey and Wexner scores were more difficult to complete due to clinical language and participants level of
comprehension. Women identified three major themes that were barriers for disclosing incontinence, which included
social expectations, trusted space and confusion.
Conclusion: There are barriers for disclosing AI in the pregnant and post-natal population, which can be improved
with the use of an easy assessment tool. The BSQ may facilitate discussion on AI between the patient and health
professional leading to earlier identification and improvement in short and long-term health outcomes.
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Background
Anal incontinence (AI) has a detrimental impact on
quality of life. The cause of AI is multifactorial including
direct/indirect trauma to muscle and nerves of the pelvic
floor following vaginal births [1–4]. Compounding injury
to the pelvic floor with subsequent birthing increases the
risk of worsening symptoms of AI for women in both
the short and long term [2, 5]. Evidence exists to support
the use of bowel screening tools in the identification of
AI within the pregnant and postnatal population [6–8].
Screening tools are adopted for research but limited in
clinical practice as research identifies specialities in-
volved in obstetrics and gynaecology rarely screen
women for AI [9]. Importantly, there is no tool, rou-
tinely used to screen this at risk group, and the true
prevalence of AI in women of reproductive age remains
unknown.
Clinically derived bowel screening tools have been uti-
lised in research to report AI in women in the late stages of
pregnancy (8–65%), following birth (16–49%), gynaecology
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outpatients (16–28%), and in the general population (4.4%)
[6, 10]. The wide variations in reporting may be a conse-
quence of the definitions utilised to identify AI, the sample
size, population studied, selective disclosure, the length and
language comprehension of the questionnaire, how the tool
was administered [8, 11–14]. Understanding the limitations
of the current assessment tools in the identification of AI
assists in defining true prevalence and improving the care
and management for women of reproductive age.
Minimal research has explored the reasons for dis-
cordance between different screening tools from the
afflicted person’s perspective. Research undertaken by
Bartlett et al. [11] identified disagreement between two
bowel screening tools, the Self-Administered Faecal In-
continence Questionnaire (SAFIQ) and the Cleveland
Clinic Florida Faecal Incontinence Score (CCF-FI). Bart-
lett et al. [11] cited terminology and embarrassment
were barriers to disclosure and suggested direct enquiry
by a health professional utilising an AI questionnaire, in
language that was easily understood could improve dis-
closure. Qualitative research by Tucker et al. [15] identi-
fied that women with a history of obstetric anal
sphincter injury experienced barriers for disclosing AI
and concur with these findings. Concurrent research
identified active screening with assessment tools in-
creased reporting of AI [8]. These findings instigated the
development of a Bowel Screening Questionnaire (BSQ).
The design and pilot testing of the BSQ included quali-
tative interviews with a group of symptomatic women.
The aim of the qualitative research was to explore and
develop an understanding of women’s experiences in
disclosing AI when completing the BSQ and two estab-
lished bowel assessment tools.
Methods
Ethical approval was provided through the University
of Adelaide Human Research Ethics Committee and
the Human Research Ethics Committee (HREC/14/
TQEHLMHMH/58). Research was undertaken be-
tween January 2015 and May 2017 and forms part of
a larger research project. The research aimed to de-
velop and validate the BSQ to identify AI in antenatal
women attending a large tertiary hospital within a
low socio-economic demographic area in South
Australia. The antenatal triaging midwives invited par-
ous women in their first trimester of a subsequent
pregnancy with a previous history of AI to participate
in the qualitative research. Nulliparous and asymp-
tomatic women were not included.
Confidentiality was maintained for women who con-
sented to the research. All texts were de-identified and
information stored on a secure password protected uni-
versal serial bus. Women were aware that if the research
caused any distress they could be referred to appropriate
services or withdraw from the research without penalty.
The main author (JT) undertook interviews. The Con-
solidated criteria for reporting qualitative research
(COREQ) guidelines were adhered to for the research.
Interpretive phenomenology was adopted as a frame-
work for this research [16]. A qualitative research
method utilising semi-structured open-ended interviews,
verbatim-transcribed text and journaling was used to ex-
plore and develop an understanding of women’s experi-
ences of disclosing AI. Interviews were audio taped
which enabled the researcher and women to immerse
themselves within the conversations, and to record the
realm of emotions and depth of the women’s individual
experiences. Recruitment continued until no new themes
were evident and saturation of data occurred at 16
women.
Research interviews were undertaken at a place and
time that was convenient for the woman. Prior to the
interview, women completed three bowel assessment
tools including BSQ specifically developed by our team
for the improved identification of AI. It was compared
to the St Mark’s faecal incontinence score (Vaizey score)
and Cleveland score (Wexner score) [17, 18]. The Vaizey
and Wexner scores were included as they are frequently
cited in research for this cohort [9, 19].
The Vaizey score is a validated tool and consists of
two scoring systems with a five-point scale, which evalu-
ates type and frequency of solid/liquid stool loss, flatus
incontinence and impact on quality of life [18]. The Vai-
zey score is based on the Wexner score (non-validated
score), the former including constipation and rectal ur-
gency [19].The scoring system assesses symptoms over
the last month and ranges from 0 (continent) to 24 (total
incontinence). Both the Vaizey and Wexner scores are
utilised in clinical studies and surgical therapies [19].The
development of the BSQ occurred in consultation with
health professionals and women with a history of AI.
After review of questions, frequency scales and symptoms
from establish tools for AI; the BSQ consisted of a symp-
tom scale similar to the Vaizey and Wexner scores. The
BSQ included six items prefaced with the statement “have
you ever lost by accident?” included additional symptoms
of staining, soiling, and request for referral (Table 1). A
frequency scale measured symptoms and utilised a scale 0
(never) to four (daily) not unlike the Vaizey and Wexner
scores. Previous research identified the variable nature of
AI impacting on young women’s quality of life as such no
timeframe was included [15, 20, 21].
Interviews began by asking the woman to describe
what it was like living with AI and to share what factors
influenced or inhibited the disclosure of AI when using
the three assessment tools. Initially there was uneasiness
with the interview process through limited depth to re-
sponses and nonverbal body language. The style of the
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interview encouraged rapport and empathy through a
conversational nature, with interviews typically lasting
between 30 to 50 min. Women were able to seek assist-
ance or clarification from the researcher in the comple-
tion of the tools.
Data analysis
Transcribed verbatim texts, audio recordings and journal
entries were analysed utilising Van Manen’s thematic
analysis [16].The backwards and forwards process of the
hermeneutic circle within the research process assisted
in the reflection and uncovering the essence of women’s
experiences. The repetitious reading and writing of data
further developed meaning. Thematic analysis uncovered
significant statements and led to the development of
three themes and four sub-themes (Tables 2 and 3).
Results
Participating women (n = 16) were aged between 22 and
42 years and had a history of AI. All women identified
English as first language; and were either Caucasian (n =
13, 81%) or Aboriginal (n = 3, 19%). Participants were
predominately (75%) presenting in a second pregnancy,
with 25% of women in their third pregnancy. Mode of
birth included normal vaginal delivery (n = 13, 81%), for-
ceps (n = 2, 13%) and caesarean section (n = 1, 6%).
Women who were symptomatic of AI following their
principal birth accounted for 12 women (75%) with four
women (25%) in their second pregnancy. Twelve women
(75%) described a history of obstetric anal sphincter
injury. Nine (75%) of these women reported the onset of
AI following sphincter injury (Table 4).
Initial interpretation of the screening tools
All women who participated in the qualitative interviews
completed and provided a detailed account of disclosing
AI using the assessment tools, the Vaizey score, Wexner
score and BSQ. Women were unaware the BSQ had
been newly designed to assess AI. Women identified a
disparity in reporting between the three assessments
tools, the BSQ easily completed and the Vaizey and
Wexner were more difficult to complete due to clinical
language and comprehension. The Vaizey and Wexner
scores required the assistance of the researcher to
understand aspects of the tools.
The Vaizey score was reported to be the most difficult
to understand due to the clinical language, including in-
continence, stool, plug and defecation. The variability of
liquid, solid stool and flatus were assessed by a scoring
system from zero to four for each symptom. However,
women were critical that the Vaizey score reported
symptoms in the last month. Additionally, the absence
of a scale to identify the frequency of rectal urgency con-
sidered by women to underrepresent the variability of
their symptoms.
Whilst the Wexner score included clinical language,
women described the wording of this tool easier to
understand and the preferred option to the Vaizey score.
The Wexner score provided a frequency scale for symp-
toms with no timeframe. However, women detailed the
Table 1 Bowel screening questionnaire (BSQ)
BSQ Qualitative interviews Never Rarely Sometimes Weekly Daily
Answer the questions by placing a tick in the column 0 1 2 3 4






Do you need to rush to the toilet
Total score /24 > 0 consider referral
Would you like to be referred to a specialist Doctor?(Circle response) Yes No
Table 2 Themes, sub themes and meanings
Theme Sub theme Meaning
Social expectation Birthing process Normal consequence, worse in subsequent delivery
Keeping it hidden Self-preservation, avoiding shame, waiting to be asked
Trusted space Finding a voice Safe environment to tell, Being safe, knowing someone understands, listen too,
sensitive questions, help me understand the words
Confusion Understanding embarrassing words, defining words, capture variability
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exclusion of rectal urgency as a major limitation of the
Wexner score as it was a predominant symptom for
women.
The BSQ was the unanimously preferred tool, with
women describing the language and tool design easy to
understand when disclosing AI. A statement “have you
lost by accident?” prefaced the BSQ and identified solid/
liquid stools, flatus, urgency and staining and included a
frequency scale 0 (never) to four (daily). Women stated
a defined frequency scale for symptoms was preferred.
Whilst the strengths and limitations of all tools were
identified, women further described important additions
in all tools. A frequency scale that identified a past and
current history of solid/liquid stool, flatus, rectal urgency
and staining was required.
Deeper interpretation in disclosing AI
The disclosure of AI was reported as complex for most
women. Understanding what the tool actually intended
to ask influenced full disclosure. Women identified three
major themes that described how they responded to dis-
closing AI with the three assessment tools. The themes
included social expectations, trusted space and confusion
(Table 2 and 3).
Social expectations
Social expectations were an overarching theme and in-
cluded two sub themes keeping it hidden and the birth-
ing process. Women within this research identified how
this influenced the completion of the bowel assessment
tools.
Keeping it hidden
Keeping it hidden detailed how the social stigma sur-
rounding AI limited disclosure. Young women identi-
fied the daily struggle of anxiety and despair in an
attempt to maintain their dignity in society and cop-
ing with the consequences of the need to rush to the
toilet and accidental loss of gas. They limited activ-
ities of daily living.
“I feel anxious, the sound and smell is always on your
mind, you don’t go out…I feel dirty” (Participant 13).
“It took a while for me to feel confident to tell
someone, I was really embarrassed …..the urgency
was bad but I had to tell someone eventually”
(Participant 3).
Table 3 Themes, sub themes and women’s statements
Theme Sub theme Example
Social expectation Birthing process “That’s what happens after a baby… I thought it didn’t matter”
“It gets worse in your next pregnancy”
Keeping it hidden “Health professionals don’t ask and I feel horrible that I pass gas all the time”
“I would tell if someone asked me”
“ask me in words I understand”
Trusted space Finding a voice “use words that don’t make me feel any more disgusted in myself than I already do”
“I need to feel safe to tell…”
“How can I tell you I poo myself when I don’t know what the word stool is?”
Confusion Understanding “Telling a woman is easier… she’s been there and birthed”
“Health professionals need to be sensitive when asking….I feel dirty and disgusted in
myself already”
“I don’t understand incontinence or urge…. What do they mean?”
…what’s a plug?”
“I don’t get symptoms all the time”
“If you ask ….I would tell to get help”
Table 4 Demographic details of participants
Number n = 16
Age, yrs., mean (range)(SD®) 31 (22–42) (7)
Ethnicity n (%)
Caucasian 13 (81)




Gestation weeks, mean (range)(SD) 22 (20–28)(3.5)
English 1st language n (%) 16 (100)
BMIb mean (range)(SD) 30 (21–42)(7.5)
Mode of delivery n (%)
Normal vaginal 13 (81%)
Forceps 2 (13%)
Caesarean section 1 (6%)
History OASIS an (%) 12 (75%)
Onset of AI post OASIS 9 (75%)
AIc n (%)
Following 1st birth 12 (75%)
Following 2nd pregnancy 4 (25%)
aObstetric anal sphincter injury; bbody mass index;
cAnal incontinence®Standard deviation
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Birthing process
All women commented on the negative impact of vaginal
delivery on pelvic floor function, resulting a weakened pel-
vic floor and continence issues. There was resignation that
the birth process and size of babies would have a negative
impact on their pelvic floor, and as such, there was no rea-
son to disclose symptoms. However, the concern for wors-
ening AI was a reality with further birthing. Women
stated that symptoms were often variable but worse in
pregnancy. They were often not aware as to the clinical
significance and under reported symptoms. Women de-
scribed these concerns with the following statements,
“Women aren’t aware of the importance of AI… it’s
not seen as a problem because that comes with
birthing” (Participant 1).
“It happens to all women…doesn’t it? So it’s not a
problem, so why tell anyone” (Participant 8).
“I don’t get symptoms all the time, sometimes you get
worse in pregnancy…. I worry for it (AI) will get worse
in next pregnancy and birth. You don’t really want to
be in nappies!” (Participant 16).
Trusted space
Participants outlined several key factors to improve dis-
closure. There was the need to be in a safe environment
with those who identified with their situation enabling
women to feel comfortable in finding a voice. There was
a real sense of yearning for health professionals to ask
questions related to continence, active screening by the
health professional improved disclosure. Women
recounted how the bowel assessment tools would help
this process but the tool needed to be sensitive and use
everyday words.
“It’s never easy to tell…not in a busy place, it needs to
be private and I need to trust the health professional. I
cannot tell you if I do not understand what you are
asking me…the words are confusing. The health
professional helped me tell by asking questions
differently…I don’t understand incontinence”
(Participant 6).
“Health professionals need to ask especially for those of
us who are from different cultural
backgrounds….because I won’t tell otherwise”
(Participant 13).
“I get embarrassed about my symptoms mostly
urgency. I think health professionals need to ask
about AI. Sometimes it’s easier telling a woman,
she understands because she’s had a baby”
(Participant 14).
Confusion
The theme confusion identified the disparity in reporting
symptoms were largely a consequence of not under-
standing the questions. Women described the difficulty
in understanding definitions, clinical language and in-
ability of the tools to capture their symptoms of AI.
The women within this research study described the
important role of the health professional in completing
the screening tool and disclosing AI. The interpretation
of questions by the women often resulted in confusion
where women would respond with no symptoms if they
did not understand the language or meaning.
“What does incontinence mean? The words are
technical; I do not know what they mean… So even if I
do have urgency or staining I say I have no symptoms”
(Participant 8).
“My symptoms are all over the place especially when
I’m pregnant….the tools don’t see that? Simple words
are needed…. tricky words like continence and defer
need changing… who understands that?” (Participant 1).
“I need someone to help me understand the words; I
don’t know incontinence, urgency, and plug. I get
staining but is that liquid poo or is that different…I
am very confused. I think it’s good to sit with the
professional and discuss the questions (assessment
tools), it’s hard otherwise to understand the words”
(Participant 14).
Discussion
Disclosure of AI when utilising screening tools is reliant
on multiple factors. Social expectations, role of the
health professional, and how a screening tool is devel-
oped is pivotal in enabling or inhibiting disclosure of AI.
Social expectations were the overarching theme, which
identified AI as a taboo health and wellbeing issue in
many cultural settings. How we are socialised, will influ-
ence what illnesses we consider socially acceptable and ei-
ther inhibit or promote health-seeking behaviour. The
inability to conform to societal norms and the mere
thought of discussing bodily functions often results in per-
sonal disgust and shame affecting disclosure [15, 22–24].
The physical and psychological impact of AI following ob-
stetric anal sphincter injury is detailed by Tucker et al.
[15] who identified the self-imposed social isolation, nega-
tive health-seeking behaviours and non-disclosure of AI
[15]. These findings concur with our research findings,
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which identified the emotional complexity surrounding
AI, stigma, embarrassment and personal disgust limited
disclosure to health professionals and full disclosure by
clinical screening tools. Embarrassment is reported as an-
other key factor in the underreporting of AI within assess-
ment tools [11].
Health seeking behaviour and disclosure relies on
those afflicted with AI to have an understanding or
knowledge of the problem [25]. Women within this re-
search identified AI was a normal consequence of birth-
ing and therefore described no reason to seek help or
disclose AI. Importantly, whilst it was acknowledged
there were concerns about worsening function in subse-
quent births disclosure was compounded as a result of
pending social stigma. Additional research supported
these findings, acknowledging nondisclosure was the re-
sult of the duality of the consequences of birthing and
embarrassment associated with AI [6, 15, 23].
The role of the health professional in the initiation of
questioning was pivotal in enabling or inhibiting disclos-
ure of AI. Tucker et al. [15] concur with these findings
further citing lack of enquiry by professionals was often
viewed by women, as the clinician having limited know-
ledge or fear of client dissatisfaction in the assessment of
continence status. Women from the current research
identified with these conclusions noting a safe environ-
ment or, a trusted space and preference for female health
professional facilitated the disclosure of AI. The partial-
ity for female health professionals in genital and anal ex-
aminations is identified in the literature to facilitate
patient centred communication, increased empathy and
resultant reduction in embarrassment in reporting symp-
toms [15, 23, 26]. Whilst there is mixed debate as to the
effectiveness of self-reported questionnaires and assess-
ment tools versus clinician assisted discussion, the benefits
of sensitive discussion with the latter have been shown to
promote disclosure of AI [7, 11, 23]. Whilst this was evi-
dent within our findings, women identified a disparity in
disclosure between the three assessments tools was a
major limitation which focused on the design of the tool,
and in particular language and comprehension.
Traditionally bowel screening and assessment tools ob-
jectively review type and frequency of AI from a clinicians
point of view [19]. The limitations of clinically derived
screening tools have been outlined previously [11, 14].
The confusion with terminology and the inability of the
screening tools to capture symptoms was evident within
our study. This is a concern for women as the underre-
porting of AI further marginalises them from adequate
clinical care and management in current and subsequent
pregnancies, potentially worsening quality of life [9, 15].
In order to disclose AI, clinical assessment tools
needed to be easy to understand. A higher reading and
comprehension level of health tools often results in
misunderstanding [27]. Leonard reported there is a need
to evaluate whether health literature is at an appropriate
level for the intended population [27]. Findings from the
current research identified women’s confusion with
terms such as continence, defecation, stool and plug in
utilising the Vaizey and Wexner scores. This may have
been a result of the study population, who were re-
cruited from a tertiary setting within a low socioeco-
nomic demographical area. Confusion often resulted in
no symptoms identified in reporting across two of the
clinically derived assessment tools the Vaizey and Wex-
ner scores. Preferred terms for incontinence included ac-
cidental leakage and is previously supported by Sung
et al. [28] who identified AI did not reflect the patients
perspective. Additionally research by Cotterill et al. [14]
identified the importance of the patient’s perspective in
the development of clinical tools and identified key areas
not previously addressed. Women in the current re-
search study identified the BSQ as the preferred assess-
ment tool; because it did not contain any of the
confusing terminology and each statement was prefaced
with “have you ever lost by accident”. The acceptability
of the BSQ may be due to the fact it was developed in
consultation with women with a history of AI.
The current research identified the disclosure of symp-
toms often relied on the variability and impact of symp-
toms on quality of life with less frequent symptoms
resulting in underreporting. Research undertaken by Bart-
lett et al. [11] supported these findings. The inability of
the Vaizey and Wexner scores to capture the frequency of
rectal urgency was cited as a limitation for this group of
women. Previous research identified the shortcomings of
assessment tools that do not incorporate the frequency of
rectal urgency [19, 29]. Rectal urgency is associated with
external anal sphincter injury and precursor of worsening
symptoms across the lifespan. The ability of screening
tools to identify the frequency of rectal urgency is import-
ant in the management of women of reproductive age.
Staining was an additional symptom women in our re-
search identified. The symptom was variable but did re-
sult in considerable bother. Sung et al. [28] utilising
qualitative research identified mucous loss as a consist-
ent finding that required acknowledgement and inclu-
sion in future frameworks on AI.
Women described the importance of a frequency scale
from zero (no symptoms) to four (daily symptoms) to
describe the variability of all symptoms. However, they
noted limitations of the assessment tools, as they did not
effectively identify the variability of symptoms across a
longer period, in particular rectal urgency. These find-
ings are consistent with previous research and promote
the development of a screening tool which identifies a
history of AI and current symptoms over the past 4
weeks [9].
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Strengths and limitations
Qualitative research findings are often limited in generalis-
ability to a larger population. However, findings from this
research may be applicable to research which aims to de-
velop tools to identify AI in this population. The research
method facilitated open disclosure and increased the rich-
ness of women’s stories but also allowed potential bias.
Research bias was reduced through the invitation for
women to take part by triaging antenatal midwives. The
nature of the research question and the researcher’s role
as a health professional may have influenced full disclos-
ure. Despite this, the research methods facilitated open
disclosure. The absence of a defined timeframe for the
BSQ may be seen as a further limitation if utilised as a
standalone tool. However, the aim of the BSQ was to be
utilised in clinical practice to screen for AI and promote
discussion of symptoms. Findings of the research-
identified women wanted both historical and current
symptoms identified by assessment tools and provides fur-
ther information for future tool development.
Conclusion
Findings of this research identify factors, which enabled
and inhibited disclosure of AI utilising three bowel as-
sessment tools. Women in this research identified the
construction and development of screening and assess-
ment tools should consider the appropriate language,
comprehension of the tool, account for the variable na-
ture of AI, the frequency of rectal urgency and staining.
The BSQ was the preferred screening tools, as it was
easy to understand and quick to utilise. However,
women described the need for tools to include both his-
torical and current symptom for AI. Whilst the findings
are important for developing screening tools there is an
urgent need by clinicians to understand the social stigma
surrounding AI and the importance of using sensitive
language in a safe environment to facilitate disclosure.
Utilising screening tools like the BSQ in the pregnant
and postnatal population will assist with disclosure and
the early detection of AI that improves a woman’s short
and long-term management and health outcomes.
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